tiprankstipranks
Trending News
More News >
Waystar Holding Corp. (WAY)
NASDAQ:WAY
US Market

Waystar Holding Corp. (WAY) AI Stock Analysis

Compare
162 Followers

Top Page

WAY

Waystar Holding Corp.

(NASDAQ:WAY)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
$33.00
▲(1.29% Upside)
Waystar Holding Corp. shows strong financial performance and positive earnings call highlights, particularly with its revenue growth and strategic acquisition. However, the stock's technical indicators suggest a bearish trend, and its high P/E ratio indicates potential overvaluation. These factors contribute to a balanced overall score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business expansion, enhancing long-term financial stability.
AI-Powered Innovations
AI-driven innovations improve operational efficiency and client satisfaction, strengthening competitive advantage in healthcare solutions.
Strategic Acquisition
The acquisition expands the client base and enhances product offerings, positioning Waystar for sustained growth and market leadership.
Negative Factors
Data Fragmentation Challenges
Data fragmentation can hinder AI effectiveness, limiting the potential benefits of technological advancements and operational improvements.
Integration and Cybersecurity Concerns
Integration and cybersecurity issues pose risks to operational integrity and client trust, potentially affecting long-term business reliability.
Potential Seasonality Impact
Seasonal revenue fluctuations may lead to inconsistent cash flows, impacting financial planning and stability over time.

Waystar Holding Corp. (WAY) vs. SPDR S&P 500 ETF (SPY)

Waystar Holding Corp. Business Overview & Revenue Model

Company DescriptionWaystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.
How the Company Makes MoneyWaystar generates revenue through a subscription-based model, offering its software solutions to healthcare providers, which include hospitals, clinics, and outpatient facilities. The company charges fees for access to its platform, which encompasses various services such as claims management, patient billing, and analytics. Key revenue streams include recurring subscription fees, transaction fees associated with payment processing, and additional services like consulting and support. Partnerships with healthcare organizations and technology providers also contribute significantly to its revenue, as they expand Waystar's market reach and enhance service offerings.

Waystar Holding Corp. Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 24, 2026
Earnings Call Sentiment Positive
Waystar demonstrated robust revenue growth, successful acquisition integration, and significant AI-driven innovations, although challenges remain in data integration and cybersecurity. The positive client feedback and increased financial guidance reflect strong market positioning.
Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Waystar reported a 12% year-over-year revenue growth, reaching $269 million, with an adjusted EBITDA margin of 42%.
Acquisition of Iodine Software
Waystar completed the acquisition of Iodine Software, expanding the total addressable market by more than 15% and adding nearly 150 health systems to its client base.
AI-Powered Platform Innovations
Waystar introduced new AI-powered capabilities focusing on denial prevention, denial recovery, and patient financial engagement, leading to significant efficiency improvements.
Positive Client Feedback
Waystar reported a 93% confidence level from clients as a trusted partner and received two prestigious awards: Best Workplaces for Innovators in North America and Healthcare Company of the Year.
Financial Guidance Increase
Waystar raised its full-year revenue guidance to $1.085 billion to $1.093 billion and adjusted EBITDA guidance to $451 million to $455 million.
Negative Updates
Challenges in Data Fragmentation
Waystar noted ongoing challenges with data fragmentation, impacting the effectiveness of AI initiatives due to incomplete or inconsistent data.
Integration and Cybersecurity Concerns
Despite advancements, integration with existing systems and cybersecurity remain critical challenges as AI becomes increasingly embedded in processes.
Potential Seasonality Impact
Volume-based revenue decreased 4% sequentially, attributed to seasonality and a reversion of patient utilization to historical growth rates.
Company Guidance
In the Waystar Third Quarter 2025 Earnings Conference Call, the company reported strong financial performance with revenue growing to $269 million, marking a 12% year-over-year increase, and achieving an adjusted EBITDA margin of 42%. The company surpassed its guidance on both revenue and margins. Waystar's strategic acquisition of Iodine Software expanded its total addressable market by over 15%, adding nearly 150 health systems and more than 1,000 hospitals to its client base. The integration of Iodine's AI-powered mid-cycle capabilities is expected to accelerate Waystar's product roadmap by nearly two years. Waystar's platform, which integrates with over 500 electronic health records, serves over one million providers nationwide, emphasizing its role in modernizing the healthcare payment process. The company showcased its AI-driven innovations at the Waystar True North conference, highlighting significant improvements in denial prevention and recovery, which are critical given the $20 billion annual denial issue in healthcare. The company also noted a net revenue retention rate of 113% and raised its full-year revenue guidance to a range of $1.085 billion to $1.093 billion, with an expected adjusted EBITDA margin of approximately 42%.

Waystar Holding Corp. Financial Statement Overview

Summary
Waystar Holding Corp. demonstrates solid financial health with strong revenue growth and efficient cash flow management. While profitability metrics are strong, there is potential for enhancing net profit margins and return on equity to maximize shareholder value.
Income Statement
78
Positive
Waystar Holding Corp. has shown a consistent revenue growth trajectory, with a TTM revenue growth rate of 2.82%. The company maintains strong gross and EBIT margins at 67.32% and 20.80% respectively, indicating efficient cost management and operational profitability. However, the net profit margin is relatively low at 8.50%, suggesting room for improvement in net profitability.
Balance Sheet
72
Positive
The balance sheet reflects a stable financial position with a low debt-to-equity ratio of 0.40, indicating prudent leverage management. The equity ratio stands at 67.90%, showcasing a strong equity base. However, the return on equity is modest at 2.77%, suggesting limited returns on shareholder investments.
Cash Flow
85
Very Positive
Cash flow analysis reveals robust free cash flow growth of 2.14% in the TTM, with a strong operating cash flow to net income ratio of 1.99. The free cash flow to net income ratio is high at 91.45%, indicating effective cash generation relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.04B943.55M791.01M704.87M578.57M
Gross Profit704.77M627.82M541.24M489.98M426.80M
EBITDA380.67M310.36M318.55M272.62M236.37M
Net Income111.18M-19.13M-51.33M-51.45M-47.12M
Balance Sheet
Total Assets4.75B4.58B4.58B4.69B4.78B
Cash, Cash Equivalents and Short-Term Investments421.06M182.13M45.43M64.56M47.25M
Total Debt40.73M1.26B2.25B2.26B2.30B
Total Liabilities1.52B1.50B2.53B2.59B2.66B
Stockholders Equity3.22B3.08B2.05B2.11B2.12B
Cash Flow
Free Cash Flow284.52M142.50M29.94M85.20M91.86M
Operating Cash Flow307.81M169.77M51.46M102.63M106.41M
Investing Cash Flow-23.29M-27.27M-61.52M-17.43M-444.33M
Financing Cash Flow16.49M16.65M-17.15M-67.06M331.50M

Waystar Holding Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price32.58
Price Trends
50DMA
35.76
Negative
100DMA
36.39
Negative
200DMA
37.26
Negative
Market Momentum
MACD
-1.10
Positive
RSI
40.59
Neutral
STOCH
55.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WAY, the sentiment is Negative. The current price of 32.58 is below the 20-day moving average (MA) of 34.18, below the 50-day MA of 35.76, and below the 200-day MA of 37.26, indicating a bearish trend. The MACD of -1.10 indicates Positive momentum. The RSI at 40.59 is Neutral, neither overbought nor oversold. The STOCH value of 55.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WAY.

Waystar Holding Corp. Risk Analysis

Waystar Holding Corp. disclosed 58 risk factors in its most recent earnings report. Waystar Holding Corp. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Waystar Holding Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$6.73B29.0625.96%14.43%29.86%
78
Outperform
$8.27B15.4522.32%1.42%7.40%-14.45%
74
Outperform
$3.76B65.7311.81%44.34%45.96%
71
Outperform
$4.62B13.0723.75%1.69%-0.38%31.38%
70
Neutral
$11.29B31.5910.21%14.26%-15.49%
68
Neutral
$6.17B52.993.54%14.75%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WAY
Waystar Holding Corp.
32.58
-4.24
-11.52%
EPAM
Epam Systems
207.02
-41.24
-16.61%
EXLS
Exlservice Holdings
42.91
-1.79
-4.00%
G
Genpact
47.73
6.17
14.85%
SAIC
Science Applications
100.74
-9.19
-8.36%
PAY
Paymentus Holdings
30.28
-3.92
-11.46%

Waystar Holding Corp. Corporate Events

Executive/Board ChangesM&A Transactions
Waystar Completes Acquisition of Iodine Software
Positive
Oct 1, 2025

On October 1, 2025, Waystar Holding Corp. completed its acquisition of Iodine Software, enhancing its AI-powered healthcare payment platform by integrating Iodine’s clinical and financial intelligence. This acquisition expands Waystar’s market by over 15% and is expected to improve its financial profile through increased gross margin and revenue growth. The merger, valued at approximately $458.6 million in cash and stock, also led to the appointment of Lauren Young to Waystar’s board, reflecting the strategic importance of the acquisition in strengthening Waystar’s position in the healthcare industry.

Private Placements and FinancingBusiness Operations and Strategy
Waystar Announces Underwriting Agreement with J.P. Morgan
Neutral
Sep 11, 2025

On September 10, 2025, Waystar Holding Corp. announced an underwriting agreement with J.P. Morgan Securities LLC for an offering of 18,000,000 shares of its common stock. The company will not receive any proceeds from this offering, which is expected to close on September 12, 2025, indicating a strategic move that may impact stakeholders by altering the distribution of shares without affecting the company’s immediate financial position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 10, 2025